Bryan Johnson said in an X post on July 22 that he had "just cloned myself as a newborn" and that this "baby-bryan" now lives in a petri dish. He listed several possible uses for it: becoming his own "blood boy," testing therapies, growing organs for transplantation, developing new treatments, and injecting young cells. The post spread widely within hours and drew sharp criticism.
The central problem, according to the source report, was not only the public reaction but the description itself. Scientists said Johnson was not describing a newborn or even an embryo. What he outlined matches induced pluripotent stem cell technology, or iPSC, which can reset blood cells into a stem-cell-like state without using an egg and without producing an embryo.
A 21-day gap between diagnosis and the cloning claim
The report places Johnson's post in a short timeline. On July 1, he publicly disclosed that he had been diagnosed with autoimmune gastritis, a chronic condition in which the immune system attacks acid-secreting cells in the stomach. Johnson described it as "my stomach is eating itself." The report says the disease cannot be cured, can impair iron and vitamin B12 absorption, can cause anemia, and can raise the risk of gastric cancer. Clinical management usually relies on long-term nutritional supplementation. It is irreversible, but not terminal.
Then, on July 22, he announced that he had cloned himself. The gap between the two disclosures was 21 days.
Not Dolly-style cloning
The report contrasts Johnson's wording with somatic cell nuclear transfer, the method used to create Dolly the sheep in 1996 at the Roslin Institute in Scotland. That process requires an egg cell, removal of the egg nucleus, insertion of the nucleus from an adult cell, development into an embryo, and implantation into a surrogate uterus before a live animal can be born.
Johnson's account includes none of those elements.
By his own description, the method involved induced pluripotent stem cells. In practice, that means taking blood cells, placing them in a dish, and introducing four transcription factors — Oct4, Sox2, Klf4, and cMyc — to erase their differentiated state and push them back toward a condition similar to embryonic stem cells.
The report notes that Japanese scientist Shinya Yamanaka established the method in 2006 and received the Nobel Prize in Physiology or Medicine in 2012. A key reason the technique was recognized is that it does not require eggs or embryos.
That leaves Johnson with a dish of reprogrammed cells, not an embryo, fetus, infant, or a second Bryan Johnson.
What iPSCs can do now, and what they cannot
Of the uses Johnson listed, the report says the one with a real laboratory basis in the near term is testing therapies on cells. Using iPSCs for disease models and drug screening is already a standard research practice.
Growing fully formed, transplantable organs is a different matter. The report describes that goal as one of the hardest unresolved challenges in regenerative medicine, with no clear timetable available.
Why the claim may be legal while still not being cloning
The report says the US does not have a single federal criminal statute that directly makes human cloning a crime, but reproductive cloning still runs into three layers of restriction.
- The Food and Drug Administration says reproductive cloning falls under its authority and has publicly stated that it would not approve it because of safety concerns.
- Federal funding cannot be used for that work.
- Nine states have passed bans, and many of those laws target the act of implanting a cloned embryo into a uterus.
Johnson, as described in the report, did not cross that line. iPSCs do not generate embryos, so there is nothing to implant. The report's point is blunt: he could safely say "I cloned myself" precisely because what he did was not cloning in that sense.
A contrast with the He Jiankui case
The report also draws a comparison with He Jiankui's 2018 CRISPR embryo-editing case. In that episode, He edited human embryos and a pair of twin girls were born, crossing the boundary between work on cells and work that resulted in human births.
In December 2019, the Nanshan District People's Court of Shenzhen sentenced He to three years in prison for illegal medical practice and imposed a fine of 3 million yuan.
The contrast in the report is clear: one case crossed the line and brought a three-year sentence; the other did not cross it and produced a viral social media post.
The "blood boy" reference was not new
Johnson's line about becoming his own "blood boy" was also linked to an earlier experiment. In 2023, he underwent a three-generation plasma exchange. Plasma from his then-17-year-old son Talmage was infused into Johnson, and Johnson's plasma was then infused into his 70-year-old father.
Johnson later said the procedure showed no detectable benefit after a round of biomarker testing. He stopped doing it and switched to a full plasma exchange approach.
This time, the reported difference is that the source of "young cells" moved from family members to a dish.
No institution, no technical record, no outside verification
The report says nearly everything available to the public comes from Johnson's own social-media post. He has not identified the institution that carried out the work. He has not released technical documentation. He has not provided third-party verification, and there is no peer-reviewed record attached to the claim.
That leaves the evidentiary weight of the episode at the level of a first-person account on a social platform.
The report closes by recalling that the problem exposed in the Theranos case was not simply whether a technology was theoretically possible, but that outsiders were never allowed to verify what the company said it had already achieved. Johnson's diagnosis, the report says, is real. His larger claim, at least from the material now public, has not been independently verified.